Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

115
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
115
Assessment of the Rectum and Anus01:25

Assessment of the Rectum and Anus

149
Evaluating the rectum and anus plays a crucial role in conducting a thorough physical examination of the gastrointestinal system. Although it may be uncomfortable and often embarrassing for the patient, it holds immense diagnostic value, particularly in detecting gastrointestinal diseases and abnormalities. This guide will explain how to perform this assessment using inspection and palpation methods.
Rectal Inspection
Begin by inspecting the perianal and anal areas for color, texture, rashes,...
149
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

131
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
131
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

145
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
145
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

164
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
164
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

134
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
134

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rome V Criteria for Anorectal Disorders: The Good and the Useful.

Gastroenterology·2026
Same author

Evaluation of the Length of Anal High-Pressure Zone as a Barrier for Fecal Incontinence.

Journal of clinical gastroenterology·2026
Same author

Randomized Sham-Controlled Trial of Translumbosacral Neuromodulation Therapy for Fecal Incontinence.

Gastroenterology·2026
Same author

AGA Clinical Practice Update on Diagnosis and Treatment of Hemorrhoids: Expert Review.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Endoscopic-Assisted Glucose Breath Test (EAGBT) for Evaluating Distal Small Intestinal Bacterial Overgrowth (SIBO): Correlation of Nuclear Imaging With Breath Testing.

Neurogastroenterology and motility·2026
Same author

Resting and Squeeze Anal Pull-Through Assessments by Fecobionics Demonstrate Weak Anal Sphincters in Patients With Fecal Incontinence.

Neurogastroenterology and motility·2026

Related Experiment Video

Updated: Jun 1, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.1K

Controversies in fecal incontinence.

Andreia Albuquerque1,2, Satish S C Rao3

  • 1School of Medicine and Biomedical Sciences, Fernando Pessoa University, Gondomar 4420-096, Porto, Portugal.

World Journal of Gastroenterology
|January 22, 2025
PubMed
Summary

Fecal incontinence significantly impacts quality of life. Novel diagnostic and treatment options, including neuromodulation and cell implantation, show promise for managing this condition.

Keywords:
Anal sphincter defectsBiofeedbackEndoanal ultrasoundFecal incontinenceNeuropathySacral neuromodulation

More Related Videos

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.8K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.4K

Related Experiment Videos

Last Updated: Jun 1, 2025

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.1K
Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

2.8K
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
06:59

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings

Published on: November 9, 2016

30.4K

Area of Science:

  • Gastroenterology and Colorectal Surgery
  • Pelvic Floor Disorders
  • Neuromodulation Therapies

Background:

  • Fecal incontinence (FI) is a prevalent condition with significant quality of life implications.
  • Common causes include obstetric anal sphincter injury and anorectal surgeries.
  • Endoanal ultrasound and anorectal manometry are key diagnostic tools.

Discussion:

  • Current controversies involve screening for asymptomatic anal sphincter defects.
  • Novel diagnostic tools like translumbosacral anorectal magnetic stimulation are emerging.
  • Home biofeedback therapy offers an alternative to office-based treatments.

Key Insights:

  • The Garg incontinence score provides a comprehensive assessment of FI symptoms.
  • Translumbosacral neuromodulation therapy presents a promising novel treatment.
  • Skeletal muscle-derived cell implantation is being investigated for external anal sphincter repair.

Outlook:

  • Sacral neuromodulation shows potential for specific conditions like scleroderma and inflammatory bowel disease-related FI.
  • Further research is needed for translumbosacral neuromodulation and cell implantation therapies.
  • Advancements in diagnostics and therapies aim to improve fecal incontinence management.